Shanghai Sanyou Medical Co Ltd
SSE:688085
Cash Flow Statement
Cash Flow Statement
Shanghai Sanyou Medical Co Ltd
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
0
|
|
| Cash Taxes Paid |
(45)
|
(43)
|
(42)
|
(45)
|
(46)
|
(52)
|
(71)
|
(81)
|
(70)
|
(95)
|
(100)
|
(104)
|
(119)
|
(108)
|
(100)
|
(82)
|
16
|
51
|
65
|
(20)
|
(18)
|
|
| Change in Working Capital |
(185)
|
(203)
|
(221)
|
(219)
|
(228)
|
(252)
|
(283)
|
(304)
|
(337)
|
(331)
|
(342)
|
(366)
|
(367)
|
(383)
|
(363)
|
(323)
|
1
|
(3)
|
4
|
(318)
|
(302)
|
|
| Cash from Operating Activities |
62
N/A
|
57
-7%
|
49
-15%
|
85
+75%
|
78
-9%
|
71
-8%
|
67
-5%
|
72
+6%
|
145
+102%
|
163
+13%
|
200
+23%
|
183
-9%
|
156
-15%
|
179
+14%
|
194
+9%
|
227
+17%
|
(90)
N/A
|
(129)
-44%
|
(162)
-25%
|
11
N/A
|
44
+302%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(80)
|
(83)
|
(65)
|
(55)
|
(30)
|
(41)
|
(34)
|
(47)
|
(92)
|
(93)
|
(109)
|
(128)
|
(138)
|
(118)
|
(106)
|
(67)
|
(8)
|
(1)
|
3
|
(37)
|
(31)
|
|
| Other Items |
30
|
119
|
(612)
|
(745)
|
(800)
|
(534)
|
121
|
199
|
104
|
(13)
|
(166)
|
(86)
|
(18)
|
19
|
127
|
118
|
(194)
|
(245)
|
(346)
|
(196)
|
(235)
|
|
| Cash from Investing Activities |
(50)
N/A
|
36
N/A
|
(677)
N/A
|
(800)
-18%
|
(830)
-4%
|
(575)
+31%
|
87
N/A
|
152
+75%
|
12
-92%
|
(106)
N/A
|
(275)
-158%
|
(214)
+22%
|
(156)
+27%
|
(99)
+36%
|
21
N/A
|
51
+141%
|
(202)
N/A
|
(247)
-22%
|
(343)
-39%
|
(234)
+32%
|
(266)
-14%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
0
|
(14)
|
0
|
180
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
(36)
|
(36)
|
(36)
|
0
|
(38)
|
(38)
|
(37)
|
0
|
(19)
|
(19)
|
(2)
|
(3)
|
(3)
|
(23)
|
(20)
|
|
| Other |
(0)
|
0
|
978
|
978
|
978
|
0
|
(3)
|
(3)
|
(1)
|
(2)
|
(1)
|
(1)
|
(5)
|
(4)
|
(3)
|
(5)
|
1
|
1
|
1
|
(6)
|
(209)
|
|
| Cash from Financing Activities |
(0)
N/A
|
0
N/A
|
978
N/A
|
978
N/A
|
978
N/A
|
0
N/A
|
(39)
N/A
|
(39)
0%
|
(37)
+4%
|
(38)
-2%
|
(38)
0%
|
(39)
-1%
|
(42)
-8%
|
(42)
+1%
|
(23)
+46%
|
(24)
-6%
|
20
N/A
|
(1)
N/A
|
(16)
-1 293%
|
(28)
-78%
|
(49)
-75%
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
3
|
3
|
(0)
|
1
|
|
| Net Change in Cash |
12
N/A
|
93
+694%
|
350
+276%
|
263
-25%
|
225
-15%
|
474
+111%
|
116
-76%
|
185
+60%
|
120
-35%
|
19
-84%
|
(113)
N/A
|
(70)
+38%
|
(42)
+40%
|
38
N/A
|
193
+411%
|
255
+32%
|
(272)
N/A
|
(374)
-37%
|
(517)
-38%
|
(251)
+51%
|
(270)
-8%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(18)
N/A
|
(26)
-44%
|
(17)
+36%
|
31
N/A
|
47
+54%
|
30
-36%
|
34
+12%
|
25
-26%
|
53
+113%
|
70
+32%
|
91
+30%
|
55
-40%
|
18
-68%
|
60
+240%
|
88
+46%
|
161
+82%
|
(98)
N/A
|
(130)
-33%
|
(159)
-22%
|
(26)
+83%
|
13
N/A
|
|